Detalhe da pesquisa
1.
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors.
Am J Hematol
; 99(4): 763-766, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317312
2.
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib.
Haematologica
; 102(8): 1361-1367, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522574
3.
Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone.
Acta Medica (Hradec Kralove)
; 59(2): 50-3, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27526305
4.
[Impact of age on the clinical response of patients with CML treated with imatinib]. / Má vek nemocných s chronickou myeloidní leukemií pri lécbe imatinibem vliv na dosazenou lécebnou odpoved?
Vnitr Lek
; 61(9): 785-6, 788-91, 2015 Sep.
Artigo
em Cs
| MEDLINE | ID: mdl-26465277
5.
Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry.
Haematologica
; 99(8): 1395-402, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24997149
6.
No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia.
Hematol Oncol
; 32(2): 87-93, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23963760
7.
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.
Am J Hematol
; 93(10): E342-E345, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30054949
8.
Current survival measures reliably reflect modern sequential treatment in CML: correlation with prognostic stratifications.
Am J Hematol
; 88(9): 790-7, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23760739
9.
Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000--a report from the population-based CAMELIA Registry.
Eur J Haematol
; 87(2): 157-68, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21535160
10.
Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice.
Leuk Lymphoma
; 62(1): 194-202, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33021423
11.
First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter.
Leuk Res
; 81: 67-74, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31051328
12.
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.
Leukemia
; 38(4): 893-897, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38472478
13.
The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients.
Arch Med Sci
; 14(6): 1416-1423, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30393497
14.
Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia.
Am J Hematol
; 85(5): 386-9, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20425803
15.
Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase.
Leuk Res
; 28(4): 415-9, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15109543
16.
Imatinib mesylate (STI 571)--a new oral target therapy for chronic myelogenous leukemia (CML).
Acta Medica (Hradec Kralove)
; 46(3): 85-9, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14677715
17.
The multidrug resistance and apoptosis evaluation in acute myeloid leukemia cells after the in vitro doxorubicin treatment.
Acta Medica (Hradec Kralove)
; 47(3): 181-5, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15568736
18.
Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels.
Cancer Med
; 2(2): 216-25, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23634289
19.
Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profile.
PLoS One
; 6(8): e23022, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21857985
20.
Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results.
Cancer Genet Cytogenet
; 191(1): 1-9, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19389502